Clonality Analysis of Different Histological Components in Combined Small Cell and Non-Small Cell Carcinoma of the Lung

Human Pathology

Volumn 34, Issue 11, 2003, Pages 1178-1184

  Murase, Takayuki ^a   Takino, Hisashi ^a   Shimizu, Shigeki ^a   Inagaki, Hiroshi ^a   Tateyama, Hisashi ^a   Takahashi, Emiko ^a   Matsuda, Hideko ^a   Eimoto, Tadaaki ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

CD56; Chromosome 3p; Combined small cell carcinoma; Loss of heterozygosity; Lung cancer; p53 gene; Point mutation

Indexed keywords

PROTEIN P53;

ADENOCARCINOMA; ADULT; AGED; ALLELE; ARTICLE; CARCINOGENESIS; CHROMOSOME 3P; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE LOSS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG EXAMINATION; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; MUTATIONAL ANALYSIS; POINT MUTATION; SQUAMOUS CELL CARCINOMA;

EID: 0345448821     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.humpath.2003.05.001     Document Type: Article

References (26)

1. Colby TV, Koss MN, Travis WD: Atlas of Tumor Pathology: Tumors of the Lower Respiratory Tract, 3rd Series, Fascicle 13. Washington, DC, Armed Forces Institute of Pathology, 1994
2. Tetu B, Ro JY, Ayala AG, et al: Small cell carcinoma of the prostate. Part I: A clinicopathologic study of 20 cases. Cancer 59:1803-1809, 1987
3. Ro JY, Tetu B, Ayala AG, et al: Small cell carcinoma of the prostate. Part II: Immunohistochemical and electron microscopic studies of 18 cases. Cancer 59:977-982, 1987
4. Attar BM, Lenvendoglu H, Rhee H: Small cell carcinoma of the esophagus: Report of three cases and review of the literature. Dig Dis Sci 35:145-152, 1990
5. Hung SS: Small cell carcinoma of the colon: A case report and literature review. J Clin Gastroenterol 11:335-339, 1989
6. Kounelis S, Jones MW, Papadaki H, et al: Carcinosarcomas (malignant mixed mullerian tumors) of the female genital tract: Comparative molecular analysis of epithelial and mesenchymal components. HUM PATHOL 29:82-87, 1998
7. Fujii H, Zhu XG, Matsumoto T, et al: Genetic classification of combined hepatocellular-cholangiocarcinoma. HUM PATHOL 31:1011-1017, 2000
8. Huang J, Behrens C, Wistuba II, et al: Clonality of combined tumors: A molecular genetic study. Arch Pathol Lab Med 126:437-441, 2002
9. Giaccone G: Oncogenes and antioncogenes in lung tumorigenesis. Chest 109:130S-134S, 1996
10. Forgacs E, Zoechbauer-Muller S, Olah E, et al: Molecular genetic abnormalities in the pathogenesis of human lung cancer. Pathol Oncol Res 7:6-13, 2001
11. Mitsudomi T, Yatabe Y, Koshikawa T, et al: Mutations of the p53 tumor-suppressor gene as clonal markers for multiple primary lung cancers. J Thorac Cardiovasc Surg 114:354-360, 1997
12. Shimizu S, Yatabe Y, Koshikawa T, et al: High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. Clin Cancer Res 6:3994-3999, 2000
13. Travis WD, Colby TV, Corrin B, et al: World Health Organization Histologic Typing of Lung Tumors, ed 3. Berlin, Springer-Verlag, 1999, pp 67-70
14. Murase T, Inagaki H, Eimoto T: Influence of histochemical and immunohistochemical stains on polymerase chain reaction. Mod Pathol 13:147-151, 2000
15. Kaufmann O, Georgi T, Dietel M: Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections. HUM PATHOL 28:1373-1378, 1997
16. X-i antigens and scarcity of neuroendocrine characteristics. Acta Pathol Jpn 41:540-551, 1941
17. Diaz-Cano SJ, Blanes A, Wolfe HJ: PCR techniques for clonality assays. Diag Mol Pathol 10:24-33, 2001
18. Usuda H, Emura I, Naito M, et al: Peripheral lung carcinomas associated with central fibrosis and mixed small cell and other histologic components. Pathol Int 45:940-946, 1995
19. Girard L, Zochbauer-Muller S, Virmani AK, et al: Genomewide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res 60:4894-4906, 2000
20. Kohno H, Hiroshima K, Toyozaki T, et al: p55 mutation and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with nonsmall cell lung carcinoma. Cancer 85:341-347, 1999
21. Hung J, Kishimoto Y, Sugio K, et al: Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. JAMA 273:558-563, 1995
22. Kishimoto Y, Sugio K, Hung JY, et al: Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers. J Natl Cancer Inst 87:1224-1229, 1995
23. Kitamura H, Kameda Y, Nakamura N, et al: Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma. Am J Pathol 146:876-887, 1995
24. Kitamura H, Kameda Y, Nakamura N, et al: Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma: Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol 20:553-562, 1996
25. Yatabe Y, Konishi H, Mitsudomi T, et al: Topographical distributions of allelic loss in individual non-small cell lung cancers. Am J Pathol 157:985-993, 2000
26. Mangum MD, Greco FA, Hainsworth JD, et al: Combined small-cell and non-small-cell lung cancer. J Clin Oncol 7:607-612, 1989